Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$130.29
-1.8%
$126.23
$99.71
$141.23
$225.97B0.695.56 million shs6.77 million shs
Baxter International Inc. stock logo
BAX
Baxter International
$34.34
-4.2%
$32.15
$28.34
$43.99
$17.57B0.64.24 million shs6.20 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$497.30
+0.7%
$569.91
$364.17
$616.00
$177.13B1.431.43 million shs2.56 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$162.93
-1.8%
$153.86
$140.68
$169.99
$392.27B0.477.09 million shs8.01 million shs
Medtronic plc stock logo
MDT
Medtronic
$91.58
-1.8%
$88.89
$75.96
$96.25
$117.45B0.86.06 million shs6.22 million shs
Stryker Co. stock logo
SYK
Stryker
$363.52
-0.5%
$382.70
$314.93
$406.19
$138.71B0.951.22 million shs1.56 million shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-3.54%-3.69%+2.68%+16.13%+10.32%
Baxter International Inc. stock logo
BAX
Baxter International
-2.18%+3.00%+17.00%+15.63%-17.58%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+2.30%-11.51%-15.31%-9.18%+30.30%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-1.02%+0.23%+8.33%+13.11%+2.87%
Medtronic plc stock logo
MDT
Medtronic
-0.33%+0.38%+3.81%+12.66%+9.29%
Stryker Co. stock logo
SYK
Stryker
-1.03%-6.39%-6.66%-2.81%+2.74%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.8553 of 5 stars
2.43.04.24.53.52.52.5
Baxter International Inc. stock logo
BAX
Baxter International
4.2777 of 5 stars
2.22.01.74.03.11.72.5
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
4.5645 of 5 stars
3.43.00.04.03.02.51.9
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.4425 of 5 stars
2.33.04.23.92.93.30.6
Medtronic plc stock logo
MDT
Medtronic
4.3794 of 5 stars
2.23.03.34.04.02.50.6
Stryker Co. stock logo
SYK
Stryker
4.7656 of 5 stars
3.43.03.34.23.02.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.84
Moderate Buy$137.945.87% Upside
Baxter International Inc. stock logo
BAX
Baxter International
2.40
Hold$38.5612.27% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.71
Moderate Buy$613.1023.28% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.56
Moderate Buy$171.335.16% Upside
Medtronic plc stock logo
MDT
Medtronic
2.44
Hold$96.074.91% Upside
Stryker Co. stock logo
SYK
Stryker
2.80
Moderate Buy$421.9016.06% Upside

Current Analyst Ratings Breakdown

Latest JNJ, ABT, ISRG, BAX, MDT, and SYK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/10/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$133.00 ➝ $150.00
3/10/2025
Baxter International Inc. stock logo
BAX
Baxter International
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$39.00 ➝ $41.00
3/10/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
3/5/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$159.00 ➝ $171.00
3/4/2025
Stryker Co. stock logo
SYK
Stryker
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$422.00
3/4/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$135.00 ➝ $160.00
3/4/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$138.00 ➝ $154.00
3/4/2025
Medtronic plc stock logo
MDT
Medtronic
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$92.00 ➝ $107.00
2/26/2025
Baxter International Inc. stock logo
BAX
Baxter International
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold ➝ Buy$42.00
2/26/2025
Stryker Co. stock logo
SYK
Stryker
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$450.00
2/24/2025
Baxter International Inc. stock logo
BAX
Baxter International
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
(Data available from 3/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.39$5.61 per share23.22$22.36 per share5.83
Baxter International Inc. stock logo
BAX
Baxter International
$10.64B1.65$5.32 per share6.45$16.69 per share2.06
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$8.35B21.21$6.55 per share75.93$46.41 per share10.72
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.42$13.39 per share12.17$29.69 per share5.49
Medtronic plc stock logo
MDT
Medtronic
$33.20B3.54$7.50 per share12.21$38.69 per share2.37
Stryker Co. stock logo
SYK
Stryker
$22.60B6.14$14.19 per share25.62$54.08 per share6.72
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.6517.0322.742.5231.95%20.74%11.19%4/16/2025 (Estimated)
Baxter International Inc. stock logo
BAX
Baxter International
-$649M-$1.28N/A12.580.93-5.05%16.67%4.93%5/1/2025 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.32B$6.4177.5865.185.8527.81%14.55%12.88%4/17/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$6.6524.5014.722.5618.20%34.24%13.63%4/15/2025 (Estimated)
Medtronic plc stock logo
MDT
Medtronic
$3.68B$3.2927.8315.712.2212.83%14.07%7.70%5/22/2025 (Estimated)
Stryker Co. stock logo
SYK
Stryker
$2.99B$7.7646.8524.512.9313.25%23.58%11.37%4/29/2025 (Estimated)

Latest JNJ, ABT, ISRG, BAX, MDT, and SYK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/20/2025Q4 2024
Baxter International Inc. stock logo
BAX
Baxter International
$0.52$0.58+$0.06-$1.00$2.67 billion$2.75 billion
2/18/2025Q3 2025
Medtronic plc stock logo
MDT
Medtronic
$1.36$1.39+$0.03$1.01$8.33 billion$8.29 billion
1/28/2025Q4 2024
Stryker Co. stock logo
SYK
Stryker
$3.87$4.01+$0.14$1.41$6.36 billionN/A
1/22/2025Q4 2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.34$1.34N/A$5.27$11.03 billion$10.97 billion
1/22/2025Q4 2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$1.99$2.04+$0.05$1.41$22.44 billion$22.52 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.81%+7.17%30.85%54 Years
Baxter International Inc. stock logo
BAX
Baxter International
$0.681.98%-1.40%N/A N/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.963.04%+5.43%74.59%63 Years
Medtronic plc stock logo
MDT
Medtronic
$2.803.06%+4.14%85.11%48 Years
Stryker Co. stock logo
SYK
Stryker
$3.360.92%+7.82%43.30%32 Years

Latest JNJ, ABT, ISRG, BAX, MDT, and SYK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/21/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.75%4/15/20254/15/20255/15/2025
2/5/2025
Stryker Co. stock logo
SYK
Stryker
quarterly$0.840.86%3/31/20253/31/20254/30/2025
3/6/2025
Medtronic plc stock logo
MDT
Medtronic
quarterly$0.703%3/28/20253/28/20254/11/2025
2/11/2025
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.172.22%2/28/20252/28/20254/1/2025
1/2/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.43%2/18/20252/18/20253/4/2025
12/13/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.592.08%1/15/20251/15/20252/14/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.32
1.60
1.14
Baxter International Inc. stock logo
BAX
Baxter International
1.31
1.43
1.09
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.07
3.22
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.43
1.11
0.86
Medtronic plc stock logo
MDT
Medtronic
0.48
1.90
1.39
Stryker Co. stock logo
SYK
Stryker
0.59
1.95
1.32

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Medtronic plc stock logo
MDT
Medtronic
82.06%
Stryker Co. stock logo
SYK
Stryker
77.09%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.73 billion1.73 billionOptionable
Baxter International Inc. stock logo
BAX
Baxter International
60,000511.63 million509.47 millionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
15,638356.18 million352.97 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,1002.41 billion2.40 billionOptionable
Medtronic plc stock logo
MDT
Medtronic
95,0001.28 billion1.28 billionOptionable
Stryker Co. stock logo
SYK
Stryker
53,000381.58 million359.07 millionOptionable

Recent News About These Companies

Stryker Co. stock logo
Stryker Co. (NYSE:SYK) Shares Acquired by Davis R M Inc.
Stryker Co. stock logo
Stryker Co. (NYSE:SYK) Shares Purchased by Amundi

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$130.29 -2.37 (-1.79%)
Closing price 03:59 PM Eastern
Extended Trading
$130.07 -0.22 (-0.17%)
As of 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Baxter International stock logo

Baxter International NYSE:BAX

$34.34 -1.51 (-4.20%)
Closing price 03:58 PM Eastern
Extended Trading
$34.37 +0.03 (+0.08%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$497.30 +3.58 (+0.73%)
Closing price 04:00 PM Eastern
Extended Trading
$497.66 +0.36 (+0.07%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$162.93 -2.93 (-1.77%)
Closing price 03:59 PM Eastern
Extended Trading
$163.10 +0.17 (+0.10%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Medtronic stock logo

Medtronic NYSE:MDT

$91.58 -1.71 (-1.83%)
Closing price 03:59 PM Eastern
Extended Trading
$91.76 +0.19 (+0.20%)
As of 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Stryker stock logo

Stryker NYSE:SYK

$363.52 -1.77 (-0.48%)
Closing price 03:59 PM Eastern
Extended Trading
$362.00 -1.52 (-0.42%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.